Eliminating residual iPS cells for safety in clinical application

Protein Cell. 2015 Jul;6(7):469-71. doi: 10.1007/s13238-015-0170-4.
No abstract available

MeSH terms

  • Animals
  • Cell Differentiation
  • Clinical Trials as Topic
  • Humans
  • Induced Pluripotent Stem Cells / cytology*
  • Mice
  • Stem Cell Transplantation*
  • Teratoma / pathology